BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19008315)

  • 1. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma.
    Belcher SM; Ma X; Le HH
    Endocrinology; 2009 Mar; 150(3):1112-21. PubMed ID: 19008315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
    Ciucci A; Meco D; De Stefano I; Travaglia D; Zannoni GF; Scambia G; Riccardi R; Saran A; Mancuso M; Gallo D
    PLoS One; 2014; 9(7):e101623. PubMed ID: 25000562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.
    Cookman CJ; Belcher SM
    Endocrinology; 2015 Jul; 156(7):2395-408. PubMed ID: 25885794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.
    Belcher SM; Burton CC; Cookman CJ; Kirby M; Miranda GL; Saeed FO; Wray KE
    BMC Pharmacol Toxicol; 2017 Sep; 18(1):63. PubMed ID: 28877739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
    J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
    Simpkins F; Hevia-Paez P; Sun J; Ullmer W; Gilbert CA; da Silva T; Pedram A; Levin ER; Reis IM; Rabinovich B; Azzam D; Xu XX; Ince TA; Yang JY; Verhaak RG; Lu Y; Mills GB; Slingerland JM
    Clin Cancer Res; 2012 Nov; 18(21):5911-23. PubMed ID: 22896656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
    Spiller SE; Logsdon NJ; Deckard LA; Sontheimer H
    BMC Cancer; 2011 Apr; 11():136. PubMed ID: 21492457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptor ß.
    Le HH; Belcher SM
    Endocrinology; 2010 Dec; 151(12):5689-99. PubMed ID: 20926581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone.
    Isgor C; Cecchi M; Kabbaj M; Akil H; Watson SJ
    Neuroscience; 2003; 121(4):837-45. PubMed ID: 14580933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries.
    Eid AH; Maiti K; Mitra S; Chotani MA; Flavahan S; Bailey SR; Thompson-Torgerson CS; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1955-61. PubMed ID: 17644575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
    Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.
    Wilk A; Waligorska A; Waligorski P; Ochoa A; Reiss K
    PLoS One; 2012; 7(3):e33867. PubMed ID: 22439007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor β signaling.
    Rahal OM; Simmen RC
    Endocrinology; 2011 Sep; 152(9):3409-21. PubMed ID: 21712365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
    Chen Y; Shang H; Zhang S; Zhang X
    J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
    Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.